📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Mucosal delivery of a vectored RSV vaccine is safe and elicits protective immunity in rodents and nonhuman primates. (2015)

First Author: Pierantoni A

Attributed to: Pre-clinical development of a simian adenovirus vectored respiratory syncytial virus (RSV) vaccine funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/mtm.2015.18

PubMed Identifier: 26015988

Publication URI: http://europepmc.org/abstract/MED/26015988

Type: Journal Article/Review

Volume: 2

Parent Publication: Molecular therapy. Methods & clinical development

ISSN: 2329-0501